| Duvakitug | TEV-48574; TEV-'574; TEV'574; SAR447189; SAR-447189; TEV574; TEV-574 | Phase 3 Clinical | Teva Pharmaceutical Industries Ltd | Asthma; Colitis, Ulcerative; Crohn Disease | 詳細 |
| Tulisokibart | PRA-023; MK-7240; PRA023 | Phase 3 Clinical | Merck Sharp & Dohme LLC, Prometheus Biosciences Inc | Arthritis, Psoriatic; Arthritis, Rheumatoid; Axial Spondyloarthritis; Colitis, Ulcerative; Crohn Disease; Hidradenitis Suppurativa; Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Non-radiographic axial spondyloarthritis; Scleroderma, Diffuse; Spondylitis, Ankylosing | 詳細 |
| Afimkibart | PF-06480605; PF 6480605; RVT-3101; RG-6631; RO-7790121 | Phase 3 Clinical | Pfizer Inc | Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Inflammatory Bowel Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease | 詳細 |
| RO-7837195 | RO-7837195; RO7837195 | Phase 2 Clinical | Genentech Inc | | 詳細 |
| PF-07261271 | RG-6730; PF-07261271 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases | 詳細 |
| SPY0-72 | SPY002-072; SPY0-72 | Phase 2 Clinical | Spyre Therapeutics Inc | Arthritis, Psoriatic; Arthritis, Rheumatoid; Axial Spondyloarthritis; Joint Diseases; Rheumatic Diseases | 詳細 |
| XmAb-942 | XmAb942; XmAb-942 | Phase 2 Clinical | Xencor Inc | Colitis, Ulcerative; Inflammatory Bowel Diseases | 詳細 |
| BCD-261 | BCD-261 | Phase 2 Clinical | BIOCAD JSC | Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases | 詳細 |
| next-generation anti-TL1A mAb (Pfizer) | | Phase 1 Clinical | Pfizer Inc | | 詳細 |
| ENV-6946 | ENV-6946 | Phase 1 Clinical | Enveda Biosciences Inc | Inflammatory Bowel Diseases | 詳細 |
| QX-030N | QX030N; CLD-423; QX-030N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Autoimmune Diseases; Inflammatory Bowel Diseases | 詳細 |
| HXN-1001 | HXN-1001 | Phase 1 Clinical | Helixon Ltd | Inflammatory Bowel Diseases; Psoriasis | 詳細 |
| GR-2303 | GR-2303 | Phase 1 Clinical | Chongqing Genrix Biopharmaceutical Co Ltd | Inflammatory Bowel Diseases | 詳細 |
| SSGJ-627 | SSGJ-627; SSGJ627 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | | 詳細 |
| SPY-002 | SPY002-091; SPY002 072; SPY-002; PR-010 | Phase 1 Clinical | Paragon Therapeutics Inc | | 詳細 |
| ABS-101(Absci) | ABS-101(Absci); ABS-101 | Phase 1 Clinical | Absci Corp | Inflammatory Bowel Diseases | 詳細 |
| FG-M701 | FG-M-701; ABBV-701; FG-M701 | Phase 1 Clinical | FutureGen Biopharm (Beijing) Co Ltd | | 詳細 |
| Next-generation anti-TL1A antibody(Telavant) | | Phase 1 Clinical | Telavant Inc | | 詳細 |